Physician profile
Reema Basu
NPI 1215173497
$561.57
in general payments reported to CMS, 2019-2025
12 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.52 · 2020: $16.12 · 2021: $16.45 · 2022: $113 · 2023: $32.28 · 2024: $133 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $214.22 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Merck Sharp & Dohme LLC | $66.47 | 2022-2025 | M-M-R II, Vaxelis, Gardasil 9 |
| Medtronic, INC. | $54.06 | 2022 | |
| Alk-Abello, INC | $51.61 | 2025 | Neffy |
| Becton, Dickinson and Company | $45.00 | 2024 | Bd Introsyte |
| Pfizer INC. | $34.56 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $22.22 | 2025 | Neffy |
| Novo Nordisk INC | $19.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.79 | 2024 | Zoryve |
| Kaleo, INC. | $13.68 | 2024 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $13.29 | 2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reema Basu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.